Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2011 | 0 | 7.999.138 | 630.835 | 2 | ||
2010 | 0 | 34.404.100 | 2.589.682 | 5 |
Total number of partners: 124
Partner loyalty:
Frequent Partner: (> 2 projects): 36
Rare Partner: 88
Frequent / Rare Partner Ratio: 0.41
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2011-11-01 | Pharmacogenomic biomarkers as clinical decision making tools for clozapine treatment of schizophrenia | CRESTAR | participant | 6.000.000 | 11 |
2011-10-01 | A Roadmap for Mental Health Research in Europe | ROAMER | participant | 1.999.138 | 14 |
2010-11-01 | Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects | ADDUCE | participant | 2.999.560 | 17 |
2010-11-01 | Suicidality: Treatment Occurring in Paediatrics | STOP | participant | 3.000.000 | 19 |
2010-05-01 | Paediatric European Risperidone Studies | PERS | participant | 5.600.000 | 21 |
2010-05-01 | European Network of National Schizophrenia Networks Studying Gene-Environment Interactions | EU-GEI | participant | 11.616.855 | 26 |
2010-02-01 | OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) | OPTiMiSE | participant | 11.187.685 | 23 |